Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.
This comprehensive five-country report contains 1,600 pages, 580 tables, and is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.
The report provides market segmentation analysis of over 100 diseases and viruses in five countries; assessment of emerging technologies; review of current instrumentation; as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis,
Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Market Segmentation Analysis
- Sales and market shares of major suppliers
of infectious disease diagnostic products,
by country and individual test.
- Test and sales forecasts for over 90 infectious disease diagnostic
assays by country, individual test and market segment:
- Blood Banks
- Commercial/Private Laboratories
- Public Health Laboratories
- Review of market dynamics, trends,
structure, size, growth and major suppliers
Current and Emerging Products
- In-depth examination of over 90 major diseases,
including etiology, current diagnostic tests,
vaccines, drugs and market needs.
- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.
- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay,and other technologies and their potential
applications for infectious disease testing.
- Extensive listings of companies developing or
marketing infectious disease diagnostic products
worldwide by individual test.
- Detailed strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.
Opportunities and Strategic Recommendations
- Emerging opportunities for new instrumentation,
reagents, IT and other products with significant market
appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Contains 1,600 pages and 580 tables
Related ReportsGlobal Infectious Disease Testing Market Global Point-of-Care Diagnostic Testing Market
SIMILAR MARKET STUDIES
This new report from Venture Planning Group contains 231 pages, 13 tables, and presents a comprehensive analysis of the French hospital hematology and flow cytometry markets, including:
November 2013 | $2900 | View Details >>
Denmark Diagnostics Market Forecasts and Opportunities: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
This new report from VPGMarketResearch.com provides granular analysis of the Australian diagnostic testing market, including volume and sales forecasts by test for the following market segments: - Blood Banking - Cancer - Chemistry - Coagulation - Drugs of Abuse - Endocrine - Hematology and Flow Cytometry - ...
July 2016 | $0 | View Details >>
2016 Future Horizons and Growth Strategies in the US Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500“2016 Future Horizons and Growth Strategies in the US Clinical Chemistry and Immunodiagnostic Markets” is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the next five years. The report explores future ...
October 2015 | $7500 | View Details >>
November 2013 | $3950 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research